Skip to content
10-Q

Quarterly Report

cbdMD, Inc. YCBD

0001437749-25-017178

← back to feed
Filed
May 15, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · May 15, 2025 8.91M sh
Dividends Paid Q2 2025 · Mar 31, 2025 $1M
Dividends Paid Q2 2025 · Mar 31, 2025 $2M
Dividends Paid Q2 2025 · Mar 31, 2024 $1M
Dividends Paid Q2 2025 · Mar 31, 2024 $2M
Cash And Equivalents Q2 2025 · Mar 31, 2025 $1.77M
Cash And Equivalents Q2 2025 · Sep 30, 2024 $2.45M
Current Liabilities Q2 2025 · Mar 31, 2025 $9.87M
Current Liabilities Q2 2025 · Sep 30, 2024 $8.62M
Total Liabilities Q2 2025 · Mar 31, 2025 $10.27M
Total Liabilities Q2 2025 · Sep 30, 2024 $8.62M
Current Assets Q2 2025 · Mar 31, 2025 $6.19M
Current Assets Q2 2025 · Sep 30, 2024 $6.39M
Total Assets Q2 2025 · Mar 31, 2025 $10.94M
Total Assets Q2 2025 · Sep 30, 2024 $10.58M
Stockholders Equity Q2 2025 · Dec 31, 2024 $1.78M
Stockholders Equity Q2 2025 · Mar 31, 2024 $3.09M
Stockholders Equity Q2 2025 · Dec 31, 2023 $7.04M
Stockholders Equity Q2 2025 · Sep 30, 2023 $9.03M
Net Income Q2 2025 · Dec 31, 2024 $15.1K
Net Income Q2 2025 · Mar 31, 2024 −$3.01M
Net Income Q2 2025 · Mar 31, 2024 −$4.01M
Net Income Q2 2025 · Dec 31, 2023 −$996.5K
Capex Q2 2025 · Mar 31, 2024 $180.02K
Operating Cash Flow Q2 2025 · Mar 31, 2024 −$809.95K
Eps Basic restated Q2 2025 · Mar 31, 2024 −$10.84
Eps Basic restated Q2 2025 · Mar 31, 2024 −$16.23
Operating Income Q2 2025 · Mar 31, 2024 −$1.55M
Operating Income Q2 2025 · Mar 31, 2024 −$2.62M
Gross Profit Q2 2025 · Mar 31, 2024 $2.58M
Gross Profit Q2 2025 · Mar 31, 2024 $6.14M
Cost Of Revenue Q2 2025 · Mar 31, 2024 $1.8M
Cost Of Revenue Q2 2025 · Mar 31, 2024 $3.61M
Revenue Q2 2025 · Mar 31, 2024 $4.38M
Revenue Q2 2025 · Mar 31, 2024 $9.75M